Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Antiallergic Drugs (Find 103 items)

Antiallergic Drugs

Loratadine

(79794-75-5)
A nonsedating-type histamine H1-receptor Antihistamines have a high degree of selectivity for peripheral nerve H1 receptors, a strong effect and a long time. Used for allergic arthritis and allergic rhinitis. National Class II anti-allergic new drug, used to relieve nasal and non-nasal symptoms of seasonal allergic rhinitis and relieve chronic urticaria

Product List

Request for quotation , get quotes from more suppliers.

Diphenhydramine

(58-73-1)
It is used for allergic diseases of the skin and mucous membranes and nausea and vomiting caused by boat ride.

Product List

Request for quotation , get quotes from more suppliers.

Cetirizine hydrochloride

(83881-52-1)
Antihistaminic Mainly used for allergic diseases of the respiratory system, skin and eyes

Product List

Request for quotation , get quotes from more suppliers.

Fexofenadine

(83799-24-0)
The active metabolite of Terfenadine (T114500), a H1-histamine receptor antagonist. Used to treat allergic rhinitis. Respiratory system and anti-allergic drugs, used to treat seasonal allergic rhinitis, chronic sudden rubella, etc.

Product List

Request for quotation , get quotes from more suppliers.

Desloratadine

(100643-71-8)
For the relief of symptoms of seasonal allergic rhinitis, perennial (non-seasonal) allergic rhinitis. Desloratidine is also used for the sympomatic treatment of pruritus and urticaria (hives) associated with chronic idiopathic urticaria.

Product List

Request for quotation , get quotes from more suppliers.

(±)-Promethazine

(60-87-7)
Antihistamines. It is suitable for allergic diseases (such as asthma, urticaria, allergic rhinitis, bronchial asthma, etc.) and vomiting during pregnancy. It can also be combined with chlorpromazine and the like to form a Keming mixture for artificial hibernation.

Product List

Request for quotation , get quotes from more suppliers.

Olopatadine

(113806-05-6)
Anti-allergic. Allergic rhinitis, allergic conjunctivitis, urticaria, skin diseases accompanied by itching symptoms (eczema, erythema multiforme, etc.) and asthma.

Product List

Request for quotation , get quotes from more suppliers.

Promethazine hydrochloride

(58-33-3)
Promethazine is a first generation histamine H1 receptor antagonist (Ki = 2.6 nM) whose antihistamine activity has been reported in guinea pigs and mice at ED50 values of 0.43 and 5.9 mg/kg, respectively.Promethazine can penetrate the CNS, depressing central H1 receptor activity, which may relate to its sedative properties, and can also inhibit muscarinic acetylcholine receptors (Ki = 22 nM). Furthermore, 32 mg/kg promethazine demonstrates antiemetic effects in ferret models of motion sickness o

Product List

Request for quotation , get quotes from more suppliers.

Epinastine

(80012-43-7)
Epinastine(WAL801) is an antihistamine and mast cell stabilizer that is used in eye drops to treat allergic conjunctivitis.Target: Histamine ReceptorEpinastine shows a high affinity to H1-receptors in receptor binding studies in the guinea pig ileum. Epinastine inhibits histamine-induced reactions in the skin or the lung of rats, dogs and guinea pigs [1]. Epinastine is able to displace specific [3H]NC-5Z binding at low concentrations in the locust nervous tissue. Epinastine binds to the

Product List

Request for quotation , get quotes from more suppliers.

An allergic reaction is an allergic reaction, which refers to tissue damage or physiological dysfunction caused by the body being stimulated by antigenic substances, and is an immunopathological injury process. Drugs for preventing and treating allergic diseases caused by various antigenic substances (such as bacteria, viruses, parasites, pollen, etc.) are anti-allergic drugs. According to the different mechanism of action, it can be divided into: antihistamine drugs, allergic reaction mediator release drugs, histamine desensitizers, leukotriene receptor antagonists, drugs that inhibit antigen-antibody reactions, and improve or control allergic symptoms Medicines, etc. The "ECHEMI Antiallergic Drugs" list mainly supplies APIs for such drugs.

Frequently Asked Questions

What are antiallergic drugs and how do they work?

Antiallergic drugs are medications designed to prevent or relieve symptoms caused by allergic reactions, such as sneezing, itching, runny nose, or hives. They primarily work by blocking histamine—a chemical released by the immune system during an allergic response—through H1 receptor antagonism. Common types include first-generation (e.g., diphenhydramine) and second-generation antihistamines (e.g., loratadine, cetirizine), which differ in sedation effects and duration of action.

What are the most commonly used antiallergic drug ingredients in pharmaceutical formulations?

The most widely used active pharmaceutical ingredients (APIs) in antiallergic drugs include loratadine, cetirizine hydrochloride, fexofenadine, desloratadine, and levocetirizine. These compounds are preferred for their non-sedating profiles, long half-lives, and high selectivity for peripheral H1 receptors. They are formulated into tablets, syrups, capsules, and oral solutions for both over-the-counter and prescription use.

What are the key quality control parameters for antiallergic drug intermediates?

Key quality control parameters for antiallergic drug intermediates include chemical purity (assessed via HPLC or GC), residual solvent levels (per ICH Q3C guidelines), heavy metal content, moisture content (via Karl Fischer titration), and structural confirmation (using NMR or FTIR). Impurity profiling is critical to ensure intermediates meet pharmacopeial standards (e.g., USP, EP) before progressing to final API synthesis.

Are there differences between generic and branded antiallergic drugs in terms of efficacy?

Generic antiallergic drugs must demonstrate bioequivalence to their branded counterparts, meaning they deliver the same active ingredient at the same rate and extent in the body. Regulatory agencies like the FDA require rigorous testing to confirm therapeutic equivalence. While excipients may differ slightly, clinical efficacy and safety profiles are generally comparable when sourced from reputable manufacturers adhering to pharmacopeial standards.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.